摘要
目的 实施神经内科危重症患者的肠内营养治疗方案,并对应用效果展开评价。方法 病例是神经内科危重症患者,样本量90例。研究时间2021年1月到2022年1月。45例入组参照组,进行常规营养治疗;45例入组肠内营养治疗组,实施肠内营养治疗方案。研究治疗前、治疗10d后的血清白蛋白(ALB)浓度、前白蛋白(PA)浓度、总蛋白(TP)浓度、血红蛋白(Hb)浓度、营养不良发生率、并发症发生率。结果 肠内营养治疗组的血清ALB浓度、PA浓度、TP浓度、Hb浓度均更高(p<0.05)。肠内营养治疗组的营养不良发生率更低(p<0.05)。肠内营养治疗组的并发症发生率更低(p<0.05)。结论 将肠内营养治疗方案用于神经内科危重症患者,对于改善患者营养指标,避免营养不良发生,促使并发症发生率降低而言,可发挥更显著的治疗价值。
关键词: 肠内营养治疗;神经内科;危重症;并发症
Abstract
Objective To implement the enteral nutrition treatment program for critically ill patients in neurology department, and evaluate the application effect. Methods Patients were critically ill in neurology depart- ment with a sample size of 90 cases. The study lasted from January 2021 to January 2022. 45 cases were enrolled into the control group and received routine nutritional therapy. Forty-five cases were enrolled into enteral nutrition treatment group and implemented enteral nutrition treatment program. The serum albumin (ALB) concentration, prealbumin (PA) concentration, total protein (TP) concentration, hemoglobin (Hb) concentration, the incidence of malnutrition and the incidence of complications were studied before and after treatment for 10 days. Results The concentrations of ALB, PA, TP and Hb were higher in enteral nutrition treatment group (P<0.05). The incidence of malnutrition was lower in enteral nutrition treatment group (P<0.05). The incidence of complications was lower in enteral nutrition group (P<0.05). Conclusion Enteral nutrition therapy for critically ill patients in neurology depart- ment can play a more significant therapeutic value in improving the nutritional indicators of patients, avoiding the occurrence of malnutrition and reducing the incidence of complications.
Key words: Enteral nutrition therapy; Department of Neurology; Critically ill; Complications
参考文献 References
[1]刘凌凌.通腑理肺汤联合早期肠内营养治疗危重症患者胃肠功能障碍的临床观察[J].中国民间疗法,2022,30(11):58-61.
[2]管石侠,张宝,侯丽丽,等.添加益生菌的早期滋养性肠内营养治疗对重症脑卒中患者胃肠功能及血清炎症因子的改善作用[J].山东医药,2022,62(14):64-67.
[3]邵萌,郭素梅.两种肠内营养液对危重症患者肠内营养支持耐受性的影响[J].深圳中西医结合杂志,2022,32(07):115-118.
[4]中国急诊危重症患者肠内营养治疗专家共识组.中国急诊危重症患者肠内营养治疗专家共识[J].中华急诊医学杂志,2022,31(03):281-290.
[5]陈欢,周伟,许锁,等.不同类型肠内营养对感染性休克患者瘦素、血清趋化素等指标及预后的影响[J].国际检验医学杂志,2021,42(18):2237-2245.
[6]米元元,黄海燕,尚游,等.中国危重症患者肠内营养治疗常见并发症预防管理专家共识(2021版)[J].中华危重病急救医学,2021,33(08):903-918.
[7]周丽娟,林展球,区月媚.舒适护理在肠内营养液治疗危重症患者期间对治疗效果的改善价值[J].中国现代医生,2021,59(09):170-172+176.
[8]秦艳枝.大黄川芎汤鼻饲联合肠内营养治疗对危重症患者肠道功能及机体免疫功能的影响[J].中国民间疗法,2021,29(04):75-77.
[9]谷金玲,龚太乾,宋伟安,等.家庭肠内营养治疗对微创食管癌根治术后营养状况的影响[J].武警医学,2020(8):4.
[10]王留晏,孔天东,姚丽鸽,等.十全大补汤肠内营养治疗胃癌术后气血两虚证的临床疗效观察[J].现代消化及介入诊疗,2022(S1).
[11]王卿.重症急性胰腺炎患者采用早期肠内营养治疗的作用——评《重症急性胰腺炎临床新技术》[J].中国实验方剂学杂志,2022,28(4):1.
[12]罗丹,王贤恩..老年心力衰竭患者肠内营养治疗与炎症因子和心功能的关系[J].国际病理科学与临床杂志,2020,040(003):653-658.